Loading...
OTCMCRLBF
Market cap374mUSD
Dec 24, Last price  
0.85USD
1D
-1.79%
1Q
-49.10%
IPO
-80.41%
Name

Cresco Labs Inc

Chart & Performance

D1W1MN
OTCM:CRLBF chart
P/E
P/S
0.49
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
40.41%
Rev. gr., 5y
77.91%
Revenues
771m
-8.52%
0000000000003,157,23210,310,00043,252,000128,534,000476,251,000821,682,000842,681,000770,885,000
Net income
-176m
L-18.68%
0000000000047,37700-1,915,000-65,302,000-36,562,000-296,834,000-215,843,000-175,522,000
CFO
59m
+212.49%
0000000034,8140083,507029,916-9,916,000-25,189,000-10,831,00014,487,00018,741,00058,564,000
Earnings
Mar 11, 2025

Profile

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of December 6, 2022, it owned and operated 55 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.
IPO date
Dec 03, 2018
Employees
3,000
Domiciled in
US
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122018‑012017‑012016‑012015‑01
Income
Revenues
770,885
-8.52%
842,681
2.56%
821,682
72.53%
Cost of revenue
486,100
506,228
485,411
Unusual Expense (Income)
NOPBT
284,785
336,453
336,271
NOPBT Margin
36.94%
39.93%
40.92%
Operating Taxes
32,950
88,938
40,107
Tax Rate
11.57%
26.43%
11.93%
NOPAT
251,835
247,515
296,164
Net income
(175,522)
-18.68%
(215,843)
-27.28%
(296,834)
711.86%
Dividends
Dividend yield
Proceeds from repurchase of equity
3,088
123,962
BB yield
Debt
Debt current
21,233
44,936
40,720
Long-term debt
834,209
816,851
723,743
Deferred revenue
17,651
Other long-term liabilities
30,723
14,770
7,001
Net debt
751,283
741,218
535,008
Cash flow
Cash from operating activities
58,564
18,741
14,487
CAPEX
(55,385)
(86,132)
(97,053)
Cash from investing activities
(44,585)
(36,577)
(163,933)
Cash from financing activities
(26,907)
(86,643)
235,005
FCF
207,185
196,638
192,583
Balance
Cash
103,429
119,341
223,543
Long term investments
730
1,228
5,912
Excess cash
65,615
78,435
188,371
Stockholders' equity
345,537
587,683
797,736
Invested Capital
1,073,386
1,099,347
1,211,803
ROIC
23.18%
21.42%
27.40%
ROCE
24.15%
26.85%
22.63%
EV
Common stock shares outstanding
323,820
298,162
262,326
Price
Market cap
EV
EBITDA
354,089
394,178
381,220
EV/EBITDA
Interest
63,243
58,516
52,149
Interest/NOPBT
22.21%
17.39%
15.51%